References
- Van Den Ouweland F A, Franssen M JAM, Van De Putte L BA, Tan Y, Van Ginneken C AM, Gribnau F WJ. Naproxen pharmacokinetics in patients with rheumatoid arthritis during active polyarticular inflammation. Br J Clin Pharmacol 1987; 23: 189–93
- Van Den Ouweland F A, Gribnau F WJ, Tan Y, Van Ginneken C AM, Van De Putte L BA. Hypoalbuminaemia and naproxen pharmacokinetics in a patient with rheumatoid arthritis. Clin Pharmacokin 1986; 11: 511–5
- Ropes M W, Bennett G A, Caleb S, Jacox R, Jesar RA. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
- Van Riel P LCM, Reekers P, Van De Putte L BA, Gribnau F WJ. Association of HLA antigens, toxic reactions and therapeutic response to auranofin and aurothioglucose in patients with rheumatoid arthritis. Tissue Antigens 1983; 22: 194–9
- Wintrobe MW. The anaemia of chronic disorders. Clinical Hematology8th edn., MW Wintrobe, GR Lee, DR Boggs, et al. Lea & Febiger, Philadelphia 1981; 646–53
- The International Committee for Standardization in Heamatology: Recommended methods for measurement of red-cell and plasma volume. J Nucl Med 1980; 21: 793–800
- Roedler H, Kaul A, Hine G. Internal radiation dose in diagnostic nuclear medicine2nd edn., H. Verlag, Hoffmann, Berlin 1981
- Van Loenhout J WA, Van Ginneken C AM, Ketelaars H CJ, Kimenai P M, Tan Y, Gribnau F WJ. A high-performance liquid chromatographic method for the quantitative determination of naproxen and desmethyl-naproxen in biological samples. J Liquid Chromatogr 1982; 5: 549–61
- Stubbé LThFL. Occult blood in faeces after administration of aspirin. Br Med J 1958; ii: 1062–6
- Leonards J R, Levy G, Niemczura R. Gastrointestinal blood loss during prolonged aspirin administration. N Engl J Med 1973; 289: 1020–1
- Lussier A, Arsenault A, Varady J. Gastrointestinal microbleeding after aspirin and naproxen. Clin Pharmacol Ther 1978; 23: 402–7
- Lussier A, Mykal D, Ménard M, Camerlain M, Arsenault A. Long-term clinical assessment of naproxen on rheumatoid arthritis patients and 51Cr gastrointestinal bleeding on volunteers. Arzneimittelforsch 1975; 25: 294–3
- Magnusson B, Sölvell L, Arvidsson B. A comparative study of gastrointestinal bleeding during administration of ketoprofen and naproxen. Scand J Rheumatol 1977; 6: 62–4
- Salom I L, Jacob G, Jallad N, Perdomo C A, Mullane J F, Weidler D. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin and naproxen in normal males. J Clin Pharmacol 1984; 24: 240–6
- Pierson R N, Holt P R, Watson R M, Keating RP. Aspirin and gastrointestinal bleeding. Chromate51 blood loss studies. Am J Med 1961; 31: 259–65
- Whitehouse M W, Rainsford-Koechli V, Rainsford KD. Aspirin gastrotoxicity. protection by various strategems. Advances in Inflammation Research, KD Rainsford, GP Velo. Raven Press, New York 1984; vol 6: 77–87, Side effects of antiinflammatory/analgesic drugs.
- Lanza F L, Nelson R S, Rack MF. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin and placebo on the gastric mucosa of healthy volunteers. J Clin Pharmacol 1984; 24: 89–95
- Hooper J W, Anslow J A, Martin W S, Araujo P, Darke A. Faecal blood loss during isoxicam and piroxicam administration for 28 days. Clin Pharmacol Ther 1985; 38: 533–7
- Bahrt K M, Korman L Y, Nashel DJ. Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs. Arch Intern Med 1984; 144: 2165–6